Back to Rankings

KURA

Kura OncologyB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
KURA vs peer average
61/100
KURA vs. peer average (B vs. C)
Grade spread
A 1 · B 4 · C 2 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

JANX is the first available peer comparator.

Closest small-cap oncology development comp in the packet for event-driven valuation behavior; useful for framing how sharply sentiment can move on clinical readouts.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerJANXJanux Therapeutics
KURA
Kura Oncology
JANX
Janux Therapeutics
Grade
B
D
Momentum
83
40
Value
41
41
Sentiment
52
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs JANX

KURA / JANX
Grade Position
In line
KURA vs. peer average (B vs. C)
61/100
Momentum
83
KURA
Value
41
KURA
Sentiment
52
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs KURA
1
JANX
JANX
D
40/100
+2
2
CGEM
CGEM
D
40/100
+2
3
PHAT
PHAT
B
80/100
Even
4
ANRO
Alto Neuroscience Inc Common
C
60/100
+1
5
PHAR
Pharming Group NV ADR
B
80/100
Even
JANX is the first peer returned for this comparison set.